However, recently, Evans et al. (2018) identified a dominant inherited 5’UTR variant associated with epigenetic silencing of BRCA1 due to promoter hypermethylation in two families affected by breast and ovarian cancer. This evidence concerns the gene BRCA1 and ovarian carcinoma.